May 8, 2025 4:30 pm EDT BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
Apr 15, 2025 8:30 am EDT BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities
Apr 10, 2025 9:15 am EDT BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States
Mar 27, 2025 4:05 pm EDT BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update
Mar 20, 2025 4:30 pm EDT BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025
Feb 27, 2025 9:45 am EST BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
Feb 26, 2025 8:15 pm EST BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update
Feb 20, 2025 8:30 am EST BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program